Future Horizons and Growth Strategies in the Japanese Blood Banking Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
[Report Updated: 02-08-2016]
Complete report ,700. DataPack (test volumes, sales forecasts, supplier shares) ,950.
VPG Market Research's new strategic analysis is prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.
During the next five years, the Japanese blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.
The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.
- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
The report explores future marketing and technological trends in the Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years.
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin,
Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s),
Antiglobulin (Direct, C3 + IgG, IgG, C3),
Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).
Infectious Disease Screening Tests
AIDS (HIV NAT, HIV-1/2), Cytomegalovirus,
Hepatitis (HAV NAT, HBV NAT, HBs Ag,
Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT,
Syphilis, West Nile Virus NAT.
Sales and Market Share Analysis
Sales and market share estimates of leading
suppliers of blood banking of reagents
and instruments, by individual product.
Strategic assessments of major suppliers and
emerging market entrants, including their sales,
product portfolios, marketing tactics, and new
products in R&D.
Market Segmentation Analysis
- Comprehensive market segmentation
analysis, including review of the market
dynamics, trends, structure, size, growth,
and key suppliers.
- Test volume and sales forecasts for over 40
blood banking tests, including NAT, by market segment:
- Blood Centers
- Commercial/Private Laboratories
Current and Emerging Products
- Analysis of current and emerging blood banking tests.
- Review of automated and semi-automated
analyzers, including their operating
characteristics, features, and selling prices.
- Assessment of current and emerging technologies,
and their potential applications for the blood banking market.
- Comprehensive lists of companies developing
or marketing new technologies and products by test.
Contains 426 pages and 41 tables
Table of Contents
for Future Horizons and Growth Strategies in the Japanese Blood Banking Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities [Report Updated: 02-08-2016]
Table of Content - click REQUEST A SAMPLE BUTTON
List Of Tables
in Future Horizons and Growth Strategies in the Japanese Blood Banking Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities [Report Updated: 02-08-2016]
- Beckman Coulter/Danaher
- Becton Dickinson
- CellMark Forensics/LabCorp
- Ortho-Clinical Diagnostic
- Proteome Sciences
- Thermo Fisher/Life Technologies
Venture Planning Group (VPG)
60088 | VPBB20249
Number of Pages
|Title||Date Published||Price from||More Details|
|Designs on the Future of Health: The ambitions of Google, Apple, et al|
IntroductionThe digital health revolution: tech giants and their impact on pharmaDrug discovery, qui...
|01 Mar 2016 by FirstWord Pharma||USD $695||More Info|
|The Future of Biosimilars 2015|
IntroductionThe Future of Biosimilars 2015 offers expert insight and opinion on the key issues facin...
|01 Jun 2015 by FirstWord Pharma||USD $2,195||More Info|
|Orphan Drug Market Access: Payer Insights on the Present and Future|
IntroductionOrphan Drug Market Access: Payer Insights on the Present and Future is a report that exa...
|14 Oct 2014 by FirstWord Pharma||USD $695||More Info|
|The Future of Cancer Immunotherapy: KOL Views Bring Opportunities into Sharp Focus|
IntroductionThere has been considerable media hype and clinical interest in cancer immunotherapy in ...
|01 Jul 2014 by FirstWord Pharma||USD $4,995||More Info|
|Physician Views: What does the future hold for new EGFR targeting NSCLC therapies?|
Scope Propelled via momentum from new data presented at the ASCO annual meeting, AstraZeneca's AZD-9...
|19 Jun 2014 by FirstWord Pharma||USD $695||More Info|
|The Future of Biosimilars: mapping critical uncertainties and the impact of future events|
IntroductionThe Future of Biosimilars: Mapping Critical Uncertainties and the Impact of Future Event...
|05 May 2014 by FirstWord Pharma||USD $1,950||More Info|
|Physician Views: What future for wearable health technology?|
Scope As the patient becomes a more proactive stakeholder in the healthcare sphere and the developme...
|24 Apr 2014 by FirstWord Pharma||USD $695||More Info|
|Physician Views: What role will device development play in the future GLP-1 agonist market?|
Scope Positioned frequently as a transitional diabetes therapy between oral agents and insulin – and...
|07 Mar 2014 by FirstWord Pharma||USD $695||More Info|
|Pharma's Future Role in CME|
IntroductionOver the last 10 years, every aspect of continuing medical education (CME) has endured m...
|01 Aug 2012 by FirstWord Pharma||USD $695||More Info|
|Branded Generics in South East Asia: Current and Future Opportunities|
IntroductionWith its fast-growing, young population and projected pharmaceutical sales in excess of ...
|01 Apr 2012 by FirstWord Pharma||USD $945||More Info|
This report is published by Venture Planning Group (VPG)
Download Free Report Summary PDF
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Accepted Card Types
Buy now using our secure payment system.